Citadel Advisors’s Cellyan Biotechnology HKPD Stock Holding History
Bought
Maintained
Sold
Other funds holding HKPD
Citadel Advisors's HKPD Position: Q3 2026 in Review
Citadel Advisors opened a new position in Cellyan Biotechnology (HKPD) in Q3 2026: 1,652 shares worth $3.83K. The stake represents ﹤0.01% of the portfolio and ranks #13818 among its holdings.
9 funds tracked by Wall St. Rank hold HKPD as of Q3 2026.
- Citadel Advisors held 1,652 shares of Cellyan Biotechnology worth $3.83K as of Q3 2026.
- Cellyan Biotechnology was a new Citadel Advisors position in Q3 2026.
- Cellyan Biotechnology made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #13818 holding.
- 9 funds tracked by Wall St. Rank held Cellyan Biotechnology as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.